FRM
AVNS

Fox Run Management’s Avanos Medical AVNS Stock Holding History

Fox Run Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51,578
Closed -$579K – 909
2025
Q4 		$579K Buy
51,578
+17,570
+52% +$201K 0.09% 435
2025
Q3 		$393K Buy
+34,008
New +$398K 0.06% 594
2018
Q4 		– Sell
-10,276
Closed -$704K – 505
2018
Q3 		$704K Sell
10,276
-3,180
-24% -$205K 0.31% 62
2018
Q2 		$770K Buy
+13,456
New +$711K 0.24% 106
2018
Q1 		– Sell
-8,338
Closed -$385K – 708
2017
Q4 		$385K Buy
+8,338
New +$383K 0.11% 376
2017
Q1 		– Sell
-23,800
Closed -$880K – 566
2016
Q4 		$880K Buy
+23,800
New +$851K 0.46% 13
2016
Q1 		– Sell
-11,300
Closed -$378K – 412
2015
Q4 		$378K Buy
+11,300
New +$351K 0.29% 97

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Fox Run Management's AVNS Position: Q1 2026 in Review

Fox Run Management sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 51,578 shares — an estimated $579K sold.

Fox Run Management first reported a position in AVNS in Q4 2015 and held it in 7 quarters. The position peaked at $880K in Q4 2016. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Fox Run Management reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Fox Run Management sold 51,578 Avanos Medical shares in Q1 2026, an estimated $579K.
  • Fox Run Management first reported a position in Avanos Medical in Q4 2015 and held it in 7 quarters.
  • Fox Run Management's Avanos Medical position peaked at $880K in Q4 2016.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.